CATALOGO DEI PRODOTTI DELLA RICERCA

VISCO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.488
NA - Nord America 5.455
AS - Asia 5.176
SA - Sud America 921
AF - Africa 139
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 18.216
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.310
RU - Federazione Russa 3.417
SG - Singapore 2.019
CN - Cina 1.729
GB - Regno Unito 741
BR - Brasile 719
HK - Hong Kong 520
VN - Vietnam 463
FR - Francia 412
DE - Germania 390
IE - Irlanda 356
IT - Italia 355
SE - Svezia 267
FI - Finlandia 181
UA - Ucraina 128
KR - Corea 96
AR - Argentina 90
CA - Canada 64
IN - India 61
NL - Olanda 56
BD - Bangladesh 51
ID - Indonesia 47
MX - Messico 47
BJ - Benin 44
AT - Austria 40
JP - Giappone 39
EC - Ecuador 37
PL - Polonia 32
ZA - Sudafrica 32
TR - Turchia 29
CO - Colombia 25
ES - Italia 25
AU - Australia 24
IQ - Iraq 23
BE - Belgio 17
CL - Cile 16
TG - Togo 15
LT - Lituania 14
MA - Marocco 14
UZ - Uzbekistan 12
PK - Pakistan 11
PY - Paraguay 10
CH - Svizzera 9
KE - Kenya 9
PE - Perù 9
VE - Venezuela 9
GR - Grecia 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
NP - Nepal 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
EG - Egitto 6
IL - Israele 6
PT - Portogallo 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AL - Albania 5
DK - Danimarca 5
NI - Nicaragua 5
AZ - Azerbaigian 4
BG - Bulgaria 4
JO - Giordania 4
MY - Malesia 4
OM - Oman 4
QA - Qatar 4
RO - Romania 4
TW - Taiwan 4
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
HR - Croazia 2
KH - Cambogia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 18.200
Salva come PNG Salva come JPEG
Città #
Moscow 1.127
Singapore 946
Dallas 905
Southend 592
Chandler 569
Jacksonville 561
Hong Kong 517
Ashburn 486
Dublin 351
Beijing 341
The Dalles 181
Munich 165
Ho Chi Minh City 158
Lawrence 152
Princeton 152
Wilmington 150
New York 140
Jinan 130
Los Angeles 124
Woodbridge 113
Nanjing 111
Shenyang 110
Helsinki 101
Hanoi 96
Houston 85
Redondo Beach 83
Buffalo 77
Tianjin 75
São Paulo 74
Hebei 68
Verona 64
London 48
Zhengzhou 47
Cotonou 44
Sindelfingen 44
Taizhou 40
Changsha 38
Jiaxing 37
Haikou 36
Ann Arbor 35
Columbus 35
Dearborn 35
Redmond 35
Santa Clara 35
Guangzhou 34
Tokyo 34
Grafing 33
Milan 32
Dong Ket 31
Hangzhou 31
Ningbo 31
Brooklyn 29
Nanchang 28
Seattle 28
Taiyuan 27
Jakarta 26
Turku 26
Warsaw 26
Lanzhou 24
Norwalk 24
San Francisco 24
Montreal 23
Council Bluffs 22
Orem 22
Boston 21
Johannesburg 21
Nuremberg 21
Belo Horizonte 20
Chicago 20
Denver 20
Redwood City 20
Vienna 20
Frankfurt am Main 19
Rio de Janeiro 19
Fuzhou 18
Guayaquil 18
Toronto 17
Washington 17
Amsterdam 16
Atlanta 16
Chennai 16
Seoul 16
Boardman 15
Haiphong 15
Lomé 15
Melbourne 15
Mexico City 15
Stockholm 15
Curitiba 14
Lappeenranta 14
Phoenix 14
Salvador 14
Biên Hòa 13
Hải Dương 13
Ankara 12
Brussels 12
Falkenstein 12
Roubaix 12
Xi'an 11
Bologna 10
Totale 10.444
Salva come PNG Salva come JPEG
Nome #
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 197
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 190
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 171
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 165
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 164
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 164
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 162
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 161
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 159
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 152
Notch Signaling Molecules as Prognostic Biomarkers for Acute Myeloid Leukemia 150
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 149
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 148
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary? 145
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma 143
A prognostic model for patients with lymphoma and {COVID}-19: a multicentre cohort study 143
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 141
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma 141
COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review 141
Efficacy of R-COMP in comparison to R-CHOP in patients with DLBCL: A systematic review and single-arm metanalysis 141
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi 139
Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice 139
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 138
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 138
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 137
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis 135
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 135
Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma 134
Life-Threatening Protein-Losing Enteropathy Due To Human Cytomegalovirus Infection Upon Immunochemotherapy 134
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma 133
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 133
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report 130
B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities 130
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis 129
Autoimmune haemolytic anaemia in mantle cell lymphoma : an insidious complication associated with leukemic disease 129
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy 126
Autoimmune cytopenias in chronic lymphocytic leukemia 126
Bendamustine plus rituximab: is it a BRIGHT idea? 125
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 124
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 124
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 123
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 121
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation 121
Genetic and phenotypic attributes of splenic marginal zone lymphoma 120
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 119
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma 118
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 118
Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and {CAR}-T Cell Therapy 117
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis 117
Pembrolizumab as salvage treatment for T-cell/histiocyte-rich and Epstein-Barr virus-positive large B-cell lymphoma 116
Toxoplasma Gondii encephalitis in two allogeneic bone marrow transplant recipients: an emerging infection after heavy immunosoppressive therapy 114
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 114
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL 114
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi 113
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma 113
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 113
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases 111
High dose sequential chemotherapy (HDSC) as salvage therapy for patients with malignant lymphomas: prognostic factors and clinical outcomes 109
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia 109
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 107
The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia 107
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study 105
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. 103
A retrospective study of R-DHAP/Ox for early progressing follicular lymphoma 103
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy 103
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 103
Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi. 102
An updated portrait of monocyte-macrophages in classical Hodgkin lymphoma 99
Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment 98
Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. 97
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study) 95
Mantle cell lymphoma patients in first relapse: we pretty much know what to do 95
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 94
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study 94
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease 93
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 93
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 93
Aggressive B-cell Lymphoma with {MYC}/{TP}53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents 93
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 92
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study 91
Computerized drug management in a Bone Marrow Transplant Unit: towards an improvement of hospital drug management 91
Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status 91
Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia 90
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas 90
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 89
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 88
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study 88
The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine 88
Long‐term results of the FIL MCL0208 trial of lenalidomide maintenance versus observation after ASCT in MCL patients 87
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies 87
The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines 86
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 86
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 85
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia 85
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study 85
STAT3 pathway is activated in ALK-positive large B-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target 85
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma 84
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 84
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy 83
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia 83
Totale 11.760
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.379
article - articoli 64.640
book - libri 0
conference - conferenze 3.739
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021426 0 0 0 0 0 166 6 18 24 20 139 53
2021/2022915 52 197 17 44 35 27 46 64 35 29 58 311
2022/20231.992 168 170 210 271 186 523 31 114 214 18 49 38
2023/20241.080 38 93 82 103 99 215 50 106 12 33 174 75
2024/20253.537 204 188 87 571 132 141 176 213 506 271 313 735
2025/20268.188 738 885 811 1.713 3.351 690 0 0 0 0 0 0
Totale 18.476